ArticlePharmacology research & perspectives2026
Enhancing Pharmacology Education Through Collaborative Innovation: The Evolution and Future of PRORENATA at an Engineering-Based Medical Program.
Article in Pharmacology research & perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Carle Illinois College of Medicine (CI MED), the first engineering-based medical program in the United States, approaches teaching medicine with an engineering innovation mindset. This approach is reflected in PRORENATA, a pioneering web application designed to address the challenge of incorporating longitudinal pharmacological concepts consistently throughout a curriculum. PRORENATA aims to alleviate resource burden and maximize the learning of pharmacologic concepts through concept mapping. A pilot version of PRORENATA was launched in 2023 and demonstrated general usability. This report shares the design and initial implementation of PRORENATA, a novel web-based medical educational resource to support medical student learning of pharmacology and its clinical applications. Following PRORENATA's pilot, a collaborative effort was established with MedTerms, another developing medical education resource, to further enhance PRORENATA. MedTerms, created by the National Center for Supercomputing Applications (NCSA) at the University of Illinois Urbana-Champaign, uses visualization design and an innovative software user interface buildout to facilitate learning of diseases from foundational principles. PRORENATA's distinguishing advantage is its foundational support by technical experts (designers, software engineers) and medical content experts (medical students, medical educators, medical specialists), ensuring content accuracy and relevance. Specifically, PRORENATA provides a visual organization of content in a tree-like structure, classifying content by class or disease states (e.g., hypertension, acute coronary syndrome, etc.). When the user clicks on specific drugs, more detailed information is revealed, including mechanism of action, key indication, common side effects, and contraindications. Each image within PRORENATA links to its source page. Ultimately, PRORENATA is a student-designed and created resource application to enhance pharmacology education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.